Answers are grounded in this paper and cite their sources.
With demonstrated noninferiority to TAP, TC is the global first-line standard for advanced endometrial cancer.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: